Clinical Trials Directory

Trials / Completed

CompletedNCT06411483

Determining the Physiological Mechanisms Behind the ObeEnd Device on Factors Regulating Appetite

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Concordia University, Montreal · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

In Canada, over 60% of adults are classified as overweight and obese resulting in a public health crisis including increasing health care costs and negatively impacting the well-being of many Canadians. To overcome these barriers, the ObeEnd device, manufactured by WAT Medical Enterprise, is a new and innovative wellness technology that uses electrical pulses to stimulate acupressure point PC6 to help control appetite. PC6 stimulation could potentially modulate appetite and restore gastric dysfunction, which are important factors that contribute to obesity. If PC6 electrostimulation facilitates the normalization of appetite and restoration of gastric dysfunction in those with obesity, then the device could be a potentially helpful aid to weight loss. To measure the change of appetite hormones and enzymes related to appetite regulation after using the ObeEnd device. The investigators hypothesize that, compared to placebo, electrostimulation of PC6 an acupuncture spot on the wrist over a two-week period will result in changes in enterogastic hormones in a direction that decreases appetite. The investigators also hypothesize that these changes will not affect physical activity levels but will correspond to changes in appetite and diet. This study will provide the first evidence of the effects of electrostimulation at PC6 on factors affecting body weight regulation providing insight into the utility of the ObeEnd device for weight control.

Conditions

Interventions

TypeNameDescription
DEVICEObeEnd BandThe ObeEnd band provides electrostimulation to the PC6 acupuncture point on the wrist for 30 minutes.
OTHERPlaceboThe nonfunctional ObeEnd band does not provide electrostimulation to the PC6 acupuncture point on the wrist for 30 minutes.

Timeline

Start date
2022-03-01
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2024-05-13
Last updated
2024-05-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06411483. Inclusion in this directory is not an endorsement.